AVE 33.3% 0.2¢ avecho biotechnology limited

the new poh, page-6

  1. 5,322 Posts.
    Only kidding re sentiment- but I do agree with all your comments- last weeks Ann has reset POHs future- the company now has clinical data that supports its business case and should provide Monsoon PR an opportunity to unleash the crows
 
watchlist Created with Sketch. Add AVE (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.